This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
28, 2025 At theAmerican College of Cardiology (ACC) 2025 meeting,GE HealthCare will introduce RevolutionVibe, i a new computed tomography (CT) system with Unlimited One-Beat Cardiac imaging to deliver consistent, high-quality images for patients, even in challenging cases like atrialfibrillation and heavily calcified coronaries.
In its announcement about the workbook, ACC noted that cardiologists use digital devices and wearable technology to remotely monitor their patients for a variety of chronic cardiovascular diseases, including heart failure, coronary artery disease, vascular disease and atrialfibrillation.
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.
These measurements can enable the early detection and monitoring of heart rhythm conditions such as atrialfibrillation. This makes FibriCheck the only smartphone application using PPG-technology that is FDA-cleared with equivalence to ECG. and reimbursed using existing reimbursement codes. business activities.
Inevitably, given its fledgling status, regulation and reimbursement is still playing catch-up, though 2023 saw some important developments in this regard. By the 1960s, advances in technology and medical research led to the emergence of automated ECG interpretation (AEI), based on physician-developed rules of classification.
AccurECG provides automated heart rate measurements, supraventricular and ventricular ectopic beat detection, and automated interpretation for 13 different arrhythmias such as atrialfibrillation, atrial flutter, and ventricular tachycardia.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content